真武汤联合紫杉醇新辅助化疗对宫颈癌病灶恶性程度的影响

真武汤联合紫杉醇新辅助化疗对宫颈癌病灶恶性程度的影响强红梅;唐军伟;赵荣;李小娣
【期刊名称】《海南医学院学报》
【年(卷),期】2018(024)008
【摘要】目的:研究真武汤联合紫杉醇新辅助化疗对宫颈癌病灶恶性程度的影响.方法:选择在南充市中心医院及遂宁市中心医院接受新辅助化疗的宫颈癌患者,随机分为两组,观察组接受新辅助化疗联合真武汤、对照组接受新辅助化疗.化疗前及化疗2个疗程后,取血清并测定肿瘤标志物的含量;化疗后,取手术切除的宫颈癌病灶并测定增殖基因、抑癌基因、侵袭基因的mRNA表达量.结果:化疗2个疗程后,两组血清中CA12-5、bFGF、SCC-Ag的含量均低于化疗前且观察组血清中CA12-5、bFGF、SCC-Ag的含量以及宫颈癌病灶内Ki-67、TK-1、SOX-2、CyclinD1、S100A6、N-cadherin、Gal-3、CatL、CatD的mRNA表达量均低于对照组,宫颈癌病灶内p53、p16、FHIT、NF2-1、LATS1的mRNA表达量均高于对照组.结论:真武汤联合紫杉醇新辅助化疗能够较单纯新辅助化疗更为有效的杀伤宫颈癌细胞、降低宫颈癌病灶的恶性程度.%Objective:To study the effect of Zhenwu decoction combined with paclitaxel neoadjuvant chemotherapy on the malignant degree of cervical cancer.Methods:Patients with cervical cancer who accepted neoadjuvant chemotherapy in Nanchong Central Hospital and Suining Central Hospital between March 2015 and June 2017 were selected and randomly divided into two groups,the observation group received neoadjuvant chemotherapy combined with Zhenwu decoction therapy,and the control group received neoadjuvant chemotherapy.Before
chemotherapy and after 2 courses of chemotherapy,the serum was collected to detect the contents of tumor markers;after chemotherapy,the surgically removed cervical cancer lesion was collected to detect the mRNA expression of proliferation genes,tumor suppressor genes and invasion genes.Results:After 2 course of chemotherapy,CA12-5,bFGF and SCC-Ag levels in serum of both groups were lower than those before treatment,and CA12-5,bFGF and SCC-Ag levels in serum as well as Ki-67,TK-1,SOX-2,CyclinD1,S100A6,N-cadherin,Gal-3,CatL and CatD mRNA expression in cervical cancer lesion of observation group were lower than those of control group whereas p53,p16,FHIT,NF2-1 and LATS1 mRNA expression in cervical cancer lesions were higher than those of control group (P ＜ 0.05).Conclusion:Zhenwu decoction combined with paclitaxel neoadjuvant chemotherapy can be more effective than neoadjuvant chemotherapy alone to kill cervical cancer cells and reduce the malignancy of cervical cancer.
【总页数】4页(P861-864)
【作者】强红梅;唐军伟;赵荣;李小娣
【作者单位】四川省南充市中心医院中西医结合科,四川南充637000;四川省南充市中心医院中西医结合科,四川南充637000;四川省南充市中心医院中西医结合科,四川南充637000;四川省遂宁市中心医院中西医结合科,四川遂宁629000
【正文语种】中文
【中图分类】R737.33
【相关文献】
1.真武汤联合新辅助化疗对卵巢癌病灶内癌细胞恶性特征的影响 [J], 周萍;申明霞;阿布拉江·艾木都拉;陈芳
2.曲妥珠单抗联合紫杉醇新辅助化疗对HER-2阳性乳腺癌病灶内细胞增殖、侵袭的影响 [J], 庹敏;彭世军;周勇;李靖;覃咸雄;于强;成宏;黎胤谋
3.紫杉醇联合卡铂新辅助化疗对局部晚期宫颈癌患者的疗效及其对免疫功能和远期预后的影响 [J], 仇玉兰;张玮;杨淑丽
4.紫杉醇联合奥沙利铂与顺铂新辅助化疗对局部晚期宫颈癌患者不良反应与KPS 评分的影响 [J], 刘敏;赵哲君;李艳萍
5.多西紫杉醇联合奥沙利铂新辅助化疗对宫颈癌患者T细胞亚群的影响 [J], 林雪娥;吴智仁;陈国仁;徐霞英
因版权原因，仅展示原文概要，查看原文内容请购买。